Chloroquine excretion following malaria prophylaxis.
Open Access
- 31 July 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 24 (2), 221-224
- https://doi.org/10.1111/j.1365-2125.1987.tb03165.x
Abstract
Urinary excretion of chloroquine and its desethyl-metabolite was monitored for up to 395 days after the last dose of oral chloroquine (300 mg base) taken once weekly for 10 weeks as malaria prophylaxis. Concentrations in plasma could be followed for up to 70 days after the last dose. A three exponential decay was applied to the urinary excretion data. The half-life of the terminal phase varied from 45 to 55 days for chloroquine and from 59 to 67 days for the metabolite. Mean residence time was approximately 20 days for the parent compound and 35 days for the metabolite, indicating that the terminal phases are of less importance for the effective half-lives.This publication has 8 references indexed in Scilit:
- Chloroquine and Desethylchloroquine in Plasma, Serum, and Whole BloodTherapeutic Drug Monitoring, 1985
- Disposition of chloroquine in man after single intravenous and oral doses.British Journal of Clinical Pharmacology, 1983
- Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- PharmacokineticsPublished by Taylor & Francis ,1982
- Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- IGPHARM: Interactive graphic package for pharmacokinetic analysisComputers and Biomedical Research, 1978
- Studies on the Pharmacology of ChloroquineArchives of Ophthalmology (1950), 1963